Cian Healthcare Share Price
13.39+0.63 (+4.94%)
+285.88% past 1 Year
Cian Healthcare Limited develops, manufactures and commercializes pharmaceutical products including sales, marketing, quality assurance, distribution, compliance and regulatory aspects under 12 therapeutic segments like Orthopaedics, Gynaecology, Paediatrics, Cardiac, Diabetic, Dermatology,
Corporate filings & documents
Announcements
As per the Attachment.
1 day agoAs per the Attachment.
1 day agoAs per the Attachment
1 day agoAs per the Attachment
1 day agoAs per the Attachment.
1 day agoAs per the Attachment.
1 day agoPlease find attached the disclosure under Regulation 30 of the SEBI (LODR) Regulations 2015.
1 week agoPlease find attached the disclosure under Regulation 30 of the SEBI (LODR) Regulations 2015.
1 week agoAs per the Attachment
1 week agoAs per the Attachment
1 week agoPlease find attached Scrutinizer Report forming part of Outcome of Postal Ballot.
1 month agoPlease find attached Scrutinizer Report forming part of Outcome of Postal Ballot.
1 month agoPlease find attached Outcome of Postal Ballot.
1 month agoPlease find attached Outcome of Postal Ballot.
1 month agoAs per the attachment.
1 month agoAs per the attachment.
1 month agoAs per the attachment.
2 months agoAs per the attachment.
2 months agoAs per the attachment.
2 months agoAs per the attachment.
2 months agoDisclosure pursuant to Regulation 30 of the SEBI Listing Regulations - Notice of Postal Ballot
2 months agoDisclosure pursuant to Regulation 30 of the SEBI Listing Regulations - Notice of Postal Ballot
2 months agoAs per the Attachment
3 months agoCian Healthcare Limited in its board meeting dated May 30 2026 has approved the audited financial results (Standalone and Consolidated) along with Audit Report and Statement on Impact of Audit Qualification for the half-year and financial year ended March 31 2026
3 months agoCian Healthcare Limited in its board meeting dated May 30 2026 has approved the audited financial results (Standalone and Consolidated) along with Audit Report and Statement on Impact of Audit Qualification for the half-year and financial year ended March 31 2026
3 months agoOutcome of the Board Meeting of Cian Healthcare Limited held on May 30 2026- Audited Financial Results (Standalone and Consolidated) for the half-year and Financial Year ended March 31 2026.
3 months agoNon-Applicability of Annual Secretarial Compliance Report for the Financial Year Ended March 31 2026 as the Company is listed on the SME Platform of BSE Limited.
3 months agoNon-Applicability of Annual Secretarial Compliance Report for the Financial Year Ended March 31 2026 as the Company is listed on the SME Platform of BSE Limited.
3 months agoCian Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve the Audited Financial Results (both Standalone and Consolidated) for the half-year and financial year ended on March 31 2026.
3 months ago<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Cian Healthcare Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24233PN2003PLC017563</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>13.55</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Rachit Malhotra <br/> Designation: Company Secretary and Cheif Complaince Officer <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Kalyani Vijay Chordia <br/> Designation: Cheif Fianancial Officer <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 20/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
4 months ago<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Cian Healthcare Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24233PN2003PLC017563</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>13.55</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Rachit Malhotra <br/> Designation: Company Secretary and Cheif Complaince Officer <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Kalyani Vijay Chordia <br/> Designation: Cheif Fianancial Officer <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 20/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
4 months agoAs per the Disclosure attached.
4 months agoAs per the Disclosure attached.
4 months agoAs per the Disclosure attached.
5 months agoAs per the Disclosure attached.
5 months agoAs per the Intimation attached.
5 months agoAs per the Intimation attached.
5 months agoAs per the attachment.
5 months agoAs per the attachment.
5 months agoThe Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Rajesh Jain
5 months agoThe Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Rajesh Jain
5 months agoThe Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Ananta Medicare Ltd
5 months agoThe Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Ananta Medicare Ltd
5 months agoThe Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Pradeep Kumar Jain
5 months agoThe Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Pradeep Kumar Jain
5 months agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Rajesh Jain & PACs
5 months agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Rajesh Jain & PACs
5 months agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Pradeep Kumar Jain & PACs
5 months agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Ananta Medicare Ltd & PACs
5 months agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Ananta Medicare Ltd & PACs
5 months agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
No data available.
Company details
Registered office
Milkat No . 3339 , Block No . 1, From South Side C . S . No . 227 /2 + 3 A, Harpale Park Opp Berger Paint , Phursungi , Tal . Haveli Pune Maharashtra PIN: 412308 Tel No: 020-26982792 Fax No: 020-26982792 Email: [email protected] Internet: www.cian.co
Registrars
Office No S6-2, 6th Floor, Pinnacle Business Park,ext to Ahura Centre, Mahakali Caves Road, Andheri (East) Mumbai - 400093(old address - Bharat Tin Works building, 1st floor, Opp. Vasant Oasis, Andheri East Mumbai - 400 059Tel: + 91 21 626 38200Fax: Office No S6-2, 6th Floor, Pinnacle Business Park Next to Ahura Centre, Mahakali Caves Road Andheri (E) PIN: Tel No: 91-022-62638200 Fax No: 91-022-62638299 Email: [email protected]
Management
Suraj Zanwar, Managing Director
Sunil Kumar, Non Executive Independent Director
Santosh Shivaji Pimparkar, Non Executive Director
Rachit Malhotra, Company Secretary and Chief Compliance Officer
Manish Goswami, Chairman
Rajesh Jain, Managing Director
Simmi Soni, Non Executive Independent Director
Details
BSE 542678
NSE NULL
ISIN INE05BN01027